| Authors: |
Lavy D; Peritoneal Surface Malignancy and Melanoma Unit, Department of Surgery B, Division of Surgery, Tel- Aviv Sourasky Medical Center, Tel- Aviv, Israel; Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel., Shimonovitz M; Peritoneal Surface Malignancy and Melanoma Unit, Department of Surgery B, Division of Surgery, Tel- Aviv Sourasky Medical Center, Tel- Aviv, Israel., Keidar D; Department of Plastic and Reconstructive Surgery, Tel- Aviv Sourasky Medical Center, Tel- Aviv, Israel., Warshavsky A; Department of Otolaryngology-Head and Neck Surgery and Maxillofacial Surgery, Tel-Aviv Sourasky Medical Center, Tel-Aviv University, Tel Aviv, Israel., Lessing Y; Peritoneal Surface Malignancy and Melanoma Unit, Department of Surgery B, Division of Surgery, Tel- Aviv Sourasky Medical Center, Tel- Aviv, Israel; Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel., Abu-Abeid A; Peritoneal Surface Malignancy and Melanoma Unit, Department of Surgery B, Division of Surgery, Tel- Aviv Sourasky Medical Center, Tel- Aviv, Israel; Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel., Schneebaum S; Peritoneal Surface Malignancy and Melanoma Unit, Department of Surgery B, Division of Surgery, Tel- Aviv Sourasky Medical Center, Tel- Aviv, Israel; Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel., Miodovnik M; Institute of Oncology, Tel- Aviv Sourasky Medical Center, Tel- Aviv, Israel., Nizri E; Peritoneal Surface Malignancy and Melanoma Unit, Department of Surgery B, Division of Surgery, Tel- Aviv Sourasky Medical Center, Tel- Aviv, Israel; Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel. Electronic address: eran.nizri@mail.huji.ac.il. |
